Technology to distinguish between bacterial and viral infections cleared
MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes
MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The approval allows it to market its products in the country
The study was conducted in patients with mild to moderate COVID-19
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Subscribe To Our Newsletter & Stay Updated